We are live on ! Find out more
GRNAW

GreenLight Biosciences Holdings, PBC Warrant

Delisted

GRNAW was delisted on the 21st of July, 2023.

27 hedge funds and large institutions have $15.4M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $9.25M → $15.4M (+$6.14M)

13% less funds holding

Funds holding: 3127 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
27
Holders Change
-4
Holders Change %
-12.9%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
10
Closed
9
Calls
$3.26M
Puts
Net Calls
+$3.26M
Net Calls Change
+$895K
Name Holding Trade Value Shares
Change
Change in
Stake
CS
26
Clear Street
New York
$2K +$1.92K +2,625 New
Morgan Stanley
27
Morgan Stanley
New York
$1K +$681 +931 New
AGM
28
Alpine Global Management
New York
$102
MF
29
Magnetar Financial
Illinois
-$386K -321,573 Closed
UOC
30
UBS O'Connor
Illinois
-$365K -307,115 Closed
CH
31
CVI Holdings
Delaware
-$300K -250,000 Closed
AA
32
AQR Arbitrage
Connecticut
-$640K -64,500 Closed
CAC
33
Cowen and Company
New York
-$64K -52,931 Closed
ICMH
34
Integrity Capital Management (HK)
Hong Kong
-$60K -50,000 Closed
PFM
35
Privium Fund Management
Netherlands
-$30K -24,735 Closed
RCM
36
Radcliffe Capital Management
Pennsylvania
-$225K -22,650 Closed
LCM
37
Lynwood Capital Management
Ontario, Canada
-$12K -10,000 Closed

GRNAW Hedge Fund Activity: Q1 2022 in Review

27 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q1 2022, worth a combined $15.4M — up 66% from $9.25M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GRNAW and 5 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was LMR Partners, adding an estimated $693K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $640K sold.

  • 27 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q1 2022, down from 31 in Q4 2021.
  • Funds reported $15.4M of GreenLight Biosciences Holdings, PBC Warrant stock for Q1 2022, up 66% quarter-over-quarter.
  • 5 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q1 2022 and 9 closed out, a net change of -4 holders.
  • The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q1 2022 was LMR Partners, an estimated $693K added.
  • The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q1 2022 was AQR Arbitrage, an estimated $640K sold.

Based on aggregated 13F filings for Q1 2022.